Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIG3 - An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study

NCT01460264 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT01460264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01460264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIG3 - An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study
Lead sponsor
Region Skane
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 16, 2013
Completion date
December 31, 2026
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, chronic obstructive pulmonary disease, lung cancer